Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe

Human papilloma virus (HPV)-related oropharyngeal carcinoma (OPC) can be considered a new subtype of cancer with different clinical characteristics and prognosis than that related to tobacco. Its incidence is increasing worldwide. Its epidemiology has been widely studied in areas such as North Ameri...

Full description

Saved in:
Bibliographic Details
Published in:International journal of environmental research and public health Vol. 19; no. 8; p. 4802
Main Authors: Rubió-Casadevall, Jordi, Ciurana, Elna, Puigdemont, Montserrat, Sanvisens, Arantza, Marruecos, Jordi, Miró, Josefina, Urban, Antoni, Palhua, Rosa-Lisset, Martín-Romero, Ferran, Ortiz-Duran, Maria Rosa, Marcos-Gragera, Rafael
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 15-04-2022
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Human papilloma virus (HPV)-related oropharyngeal carcinoma (OPC) can be considered a new subtype of cancer with different clinical characteristics and prognosis than that related to tobacco. Its incidence is increasing worldwide. Its epidemiology has been widely studied in areas such as North America and Northern Europe, but less is known in Southern Europe. We analyzed the epidemiology of OPC using the database from Girona's population-based Cancer Registry, in the North-East of Spain, from 1994 to 2018. To analyze differences between neoplasms related to human papillomavirus or not, we determined the immunohistochemical expression of p16 in cases within four time periods: 1997-1999, 2003-2005, 2009-2011, and 2016-2018. Oropharyngeal cancer incidence increased significantly from 2001 to 2018 with an Annual Percentage of Change (APC) of 4.1. OPC p16-positive cases increased with an APC of 11.1. In the most recent period, 2016-2018, 38.5% of OPC cases were p16-positive. European age-standardized incidence rate was 4.18 cases/100.000 inhabitants-year for OPC cancer and 1.58 for those p16-positive. Five-year observed survival was 66.3% for p16-positive OPC and 37.7% for p16-negative. Although with lower burden than in other regions, p16-positive oropharyngeal cancer is increasing in our area and has a better prognosis than p16-negative OPC.
AbstractList Introduction: Human papilloma virus (HPV)-related oropharyngeal carcinoma (OPC) can be considered a new subtype of cancer with different clinical characteristics and prognosis than that related to tobacco. Its incidence is increasing worldwide. Its epidemiology has been widely studied in areas such as North America and Northern Europe, but less is known in Southern Europe. Methods: We analyzed the epidemiology of OPC using the database from Girona’s population-based Cancer Registry, in the North-East of Spain, from 1994 to 2018. To analyze differences between neoplasms related to human papillomavirus or not, we determined the immunohistochemical expression of p16 in cases within four time periods: 1997–1999, 2003–2005, 2009–2011, and 2016–2018. Results: Oropharyngeal cancer incidence increased significantly from 2001 to 2018 with an Annual Percentage of Change (APC) of 4.1. OPC p16-positive cases increased with an APC of 11.1. In the most recent period, 2016–2018, 38.5% of OPC cases were p16-positive. European age-standardized incidence rate was 4.18 cases/100.000 inhabitants-year for OPC cancer and 1.58 for those p16-positive. Five-year observed survival was 66.3% for p16-positive OPC and 37.7% for p16-negative. Conclusions: Although with lower burden than in other regions, p16-positive oropharyngeal cancer is increasing in our area and has a better prognosis than p16-negative OPC.
Human papilloma virus (HPV)-related oropharyngeal carcinoma (OPC) can be considered a new subtype of cancer with different clinical characteristics and prognosis than that related to tobacco. Its incidence is increasing worldwide. Its epidemiology has been widely studied in areas such as North America and Northern Europe, but less is known in Southern Europe. We analyzed the epidemiology of OPC using the database from Girona's population-based Cancer Registry, in the North-East of Spain, from 1994 to 2018. To analyze differences between neoplasms related to human papillomavirus or not, we determined the immunohistochemical expression of p16 in cases within four time periods: 1997-1999, 2003-2005, 2009-2011, and 2016-2018. Oropharyngeal cancer incidence increased significantly from 2001 to 2018 with an Annual Percentage of Change (APC) of 4.1. OPC p16-positive cases increased with an APC of 11.1. In the most recent period, 2016-2018, 38.5% of OPC cases were p16-positive. European age-standardized incidence rate was 4.18 cases/100.000 inhabitants-year for OPC cancer and 1.58 for those p16-positive. Five-year observed survival was 66.3% for p16-positive OPC and 37.7% for p16-negative. Although with lower burden than in other regions, p16-positive oropharyngeal cancer is increasing in our area and has a better prognosis than p16-negative OPC.
Introduction: Human papilloma virus (HPV)-related oropharyngeal carcinoma (OPC) can be considered a new subtype of cancer with different clinical characteristics and prognosis than that related to tobacco. Its incidence is increasing worldwide. Its epidemiology has been widely studied in areas such as North America and Northern Europe, but less is known in Southern Europe. Methods: We analyzed the epidemiology of OPC using the database from Girona’s population-based Cancer Registry, in the North-East of Spain, from 1994 to 2018. To analyze differences between neoplasms related to human papillomavirus or not, we determined the immunohistochemical expression of p16 in cases within four time periods: 1997–1999, 2003–2005, 2009–2011, and 2016–2018. Results: Oropharyngeal cancer incidence increased significantly from 2001 to 2018 with an Annual Percentage of Change (APC) of 4.1. OPC p16-positive cases increased with an APC of 11.1. In the most recent period, 2016–2018, 38.5% of OPC cases were p16-positive. European age-standardized incidence rate was 4.18 cases/100.000 inhabitants-year for OPC cancer and 1.58 for those p16-positive. Five-year observed survival was 66.3% for p16-positive OPC and 37.7% for p16-negative. Conclusions: Although with lower burden than in other regions, p16-positive oropharyngeal cancer is increasing in our area and has a better prognosis than p16-negative OPC.
Author Marruecos, Jordi
Martín-Romero, Ferran
Ortiz-Duran, Maria Rosa
Marcos-Gragera, Rafael
Urban, Antoni
Miró, Josefina
Sanvisens, Arantza
Ciurana, Elna
Palhua, Rosa-Lisset
Rubió-Casadevall, Jordi
Puigdemont, Montserrat
AuthorAffiliation 1 Medical Oncology Department, Catalan Institute of Oncology, Hospital Josep Trueta, 17007 Girona, Spain
9 Pathology Department, Fundació Salut Emporda, Figueres Hospital, 17600 Girona, Spain; lfmartin@salutemporda.cat
3 School of Medicine, University of Girona (UdG), 17004 Girona, Spain; elna.ciurana@gmail.com (E.C.); jmarruecos@iconcologia.net (J.M.); rortizduran.girona.ics@gencat.cat (M.R.O.-D.)
2 Descriptive Epidemiology, Genetics and Cancer Prevention Group, Girona Biomedical Research Institute (IDIBGI), 17190 Girona, Spain; mpuigdemont@iconcologia.net (M.P.); asanvisens@iconcologia.net (A.S.); rmarcos@iconcologia.net (R.M.-G.)
5 Radiotherapy Oncology Department, Catalan Institute of Oncology, Hospital Josep Trueta, 17007 Girona, Spain
6 Pathology Department, Girona Clinic, 17007 Girona, Spain; pmiroap@clinicagirona.cat
10 Pathology Department, Catalan Institute of Health, Hospital Josep Trueta, 17007 Girona, Spain
8 Pathology Department, Serveis de Salut Integrats Baix Empordà, Palamos
AuthorAffiliation_xml – name: 8 Pathology Department, Serveis de Salut Integrats Baix Empordà, Palamos Hospital, 17230 Girona, Spain; rpalhua@ssibe.cat
– name: 3 School of Medicine, University of Girona (UdG), 17004 Girona, Spain; elna.ciurana@gmail.com (E.C.); jmarruecos@iconcologia.net (J.M.); rortizduran.girona.ics@gencat.cat (M.R.O.-D.)
– name: 2 Descriptive Epidemiology, Genetics and Cancer Prevention Group, Girona Biomedical Research Institute (IDIBGI), 17190 Girona, Spain; mpuigdemont@iconcologia.net (M.P.); asanvisens@iconcologia.net (A.S.); rmarcos@iconcologia.net (R.M.-G.)
– name: 10 Pathology Department, Catalan Institute of Health, Hospital Josep Trueta, 17007 Girona, Spain
– name: 5 Radiotherapy Oncology Department, Catalan Institute of Oncology, Hospital Josep Trueta, 17007 Girona, Spain
– name: 9 Pathology Department, Fundació Salut Emporda, Figueres Hospital, 17600 Girona, Spain; lfmartin@salutemporda.cat
– name: 1 Medical Oncology Department, Catalan Institute of Oncology, Hospital Josep Trueta, 17007 Girona, Spain
– name: 4 Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan Department of Health Government of Catalonia, Catalan Institute of Oncology, 17004 Girona, Spain
– name: 6 Pathology Department, Girona Clinic, 17007 Girona, Spain; pmiroap@clinicagirona.cat
– name: 7 Pathology Department, Corporació de Salut del Maresme La Selva, Hospital Sant Jaume de Calella, 08370 Barcelona, Spain; aurban@salutms.cat
Author_xml – sequence: 1
  givenname: Jordi
  orcidid: 0000-0002-3516-6970
  surname: Rubió-Casadevall
  fullname: Rubió-Casadevall, Jordi
  organization: School of Medicine, University of Girona (UdG), 17004 Girona, Spain
– sequence: 2
  givenname: Elna
  surname: Ciurana
  fullname: Ciurana, Elna
  organization: School of Medicine, University of Girona (UdG), 17004 Girona, Spain
– sequence: 3
  givenname: Montserrat
  orcidid: 0000-0001-9961-3699
  surname: Puigdemont
  fullname: Puigdemont, Montserrat
  organization: Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan Department of Health Government of Catalonia, Catalan Institute of Oncology, 17004 Girona, Spain
– sequence: 4
  givenname: Arantza
  orcidid: 0000-0001-6269-5491
  surname: Sanvisens
  fullname: Sanvisens, Arantza
  organization: Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan Department of Health Government of Catalonia, Catalan Institute of Oncology, 17004 Girona, Spain
– sequence: 5
  givenname: Jordi
  surname: Marruecos
  fullname: Marruecos, Jordi
  organization: Radiotherapy Oncology Department, Catalan Institute of Oncology, Hospital Josep Trueta, 17007 Girona, Spain
– sequence: 6
  givenname: Josefina
  surname: Miró
  fullname: Miró, Josefina
  organization: Pathology Department, Girona Clinic, 17007 Girona, Spain
– sequence: 7
  givenname: Antoni
  surname: Urban
  fullname: Urban, Antoni
  organization: Pathology Department, Corporació de Salut del Maresme La Selva, Hospital Sant Jaume de Calella, 08370 Barcelona, Spain
– sequence: 8
  givenname: Rosa-Lisset
  surname: Palhua
  fullname: Palhua, Rosa-Lisset
  organization: Pathology Department, Serveis de Salut Integrats Baix Empordà, Palamos Hospital, 17230 Girona, Spain
– sequence: 9
  givenname: Ferran
  surname: Martín-Romero
  fullname: Martín-Romero, Ferran
  organization: Pathology Department, Fundació Salut Emporda, Figueres Hospital, 17600 Girona, Spain
– sequence: 10
  givenname: Maria Rosa
  orcidid: 0000-0002-8973-0493
  surname: Ortiz-Duran
  fullname: Ortiz-Duran, Maria Rosa
  organization: Pathology Department, Catalan Institute of Health, Hospital Josep Trueta, 17007 Girona, Spain
– sequence: 11
  givenname: Rafael
  orcidid: 0000-0001-9824-3657
  surname: Marcos-Gragera
  fullname: Marcos-Gragera, Rafael
  organization: Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan Department of Health Government of Catalonia, Catalan Institute of Oncology, 17004 Girona, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35457669$$D View this record in MEDLINE/PubMed
BookMark eNpdkc9PHCEUx0ljU3-01x4bkl56GQvDDAOXJrqxarKJRm2vhIU3u2xmYArLNv4x_V9lqzXaEyR83of33vcQ7fngAaGPlBwzJslXt4Y4ragkohGkfoMOKOekajihey_u--gwpTUhTDRcvkP7rG3ajnN5gP5chykPeuOCr051AotPvB7uk0s49PgugrcJO48vvXEWvAGsvcW3OW7dVg875iKP2uNrPblhCKPGP13MqbqBIi22qximlY73fgkFn-liiDufxvPwuzrNsUjxDSzL_zvZbcibFUSPz3IphPfoba-HBB-eziP04_vZ3eyiml-dX85O5pVhjNWVYGBbznropBBNbbRloquhNVSbftHZjmvW07IIwa01srfS0kVDCYiuZZJbdoS-PXqnvBjBGvCbqAc1RTeW3lXQTr1-8W6llmGrJKk7Ktsi-PIkiOFXhrRRo0sGhkF7CDmpmrdNLRjvuoJ-_g9dhxzL0v9StRREiqZQx4-UiSGlCP1zM5SoXfLqdfKl4NPLEZ7xf1GzB3s8rzw
CitedBy_id crossref_primary_10_1007_s00784_023_05425_0
crossref_primary_10_3390_cancers15092643
Cites_doi 10.1002/cncr.31841
10.1136/sextrans-2020-054428
10.1038/s41598-020-66323-z
10.1111/j.1743-6109.2011.02511.x
10.1016/j.annonc.2020.08.1026
10.1136/bmjopen-2017-019005
10.1200/JCO.2013.50.3870
10.1002/ijc.28355
10.1007/s12094-013-1074-5
10.1002/hed.25585
10.1093/jnci/djg107
10.1056/NEJMoa0912217
10.1158/1940-6207.CAPR-19-0098
10.1038/s41598-020-70118-7
10.12998/wjcc.v2.i6.172
10.1056/NEJMoa065497
10.1016/j.oraloncology.2011.12.013
10.3390/v13071326
10.1001/jama.2013.284692
10.1093/jnci/djv403
10.1093/ije/dyp350
10.1186/1471-2407-13-220
10.1016/j.ejca.2020.04.027
10.1080/21645515.2019.1600985
10.1200/JCO.2011.36.4596
10.1002/cncr.33346
10.1016/j.canep.2011.02.012
10.1158/1055-9965.EPI-19-0038
10.1002/ijc.31315
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.3390/ijerph19084802
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database (Proquest)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content (ProQuest)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Public Health
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1660-4601
ExternalDocumentID 10_3390_ijerph19084802
35457669
Genre Journal Article
GeographicLocations Europe
United States--US
Southern Europe
GeographicLocations_xml – name: Europe
– name: Southern Europe
– name: United States--US
GroupedDBID ---
29J
2WC
2XV
3V.
53G
5GY
5VS
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
8R4
8R5
A8Z
AADQD
AAFWJ
AAHBH
ABJCF
ABUWG
ACGFO
ACGOD
ACIWK
ADBBV
AENEX
AFKRA
AFRAH
AFZYC
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ATCPS
AZQEC
BAWUL
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBD
EBS
ECM
EIF
EJD
EMB
EMOBN
ESTFP
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEP
KQ8
L6V
M1P
M2P
M48
M7S
MODMG
M~E
NPM
O5R
O5S
OK1
P2P
PATMY
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PYCSY
Q2X
RIG
RNS
RPM
SV3
TR2
UKHRP
XSB
AAYXX
CITATION
7XB
8FK
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c3332-83ed563fe798842cad3872e5c1acfb7d76a3f146086ddc9fd9d1b410e875396d3
IEDL.DBID RPM
ISSN 1660-4601
1661-7827
IngestDate Tue Sep 17 21:17:01 EDT 2024
Fri Oct 25 22:56:14 EDT 2024
Sat Nov 09 00:56:16 EST 2024
Fri Nov 22 02:43:26 EST 2024
Sat Sep 28 08:40:23 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords epidemiology
human papilloma virus
oropharyngeal cancer
p16
incidence
survival
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3332-83ed563fe798842cad3872e5c1acfb7d76a3f146086ddc9fd9d1b410e875396d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-9824-3657
0000-0001-6269-5491
0000-0001-9961-3699
0000-0002-8973-0493
0000-0002-3516-6970
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027195/
PMID 35457669
PQID 2652980984
PQPubID 54923
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9027195
proquest_miscellaneous_2654283677
proquest_journals_2652980984
crossref_primary_10_3390_ijerph19084802
pubmed_primary_35457669
PublicationCentury 2000
PublicationDate 20220415
PublicationDateYYYYMMDD 2022-04-15
PublicationDate_xml – month: 4
  year: 2022
  text: 20220415
  day: 15
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of environmental research and public health
PublicationTitleAlternate Int J Environ Res Public Health
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Rietbergen (ref_26) 2018; 143
Chaturvedi (ref_7) 2013; 31
Ng (ref_29) 2014; 311
Beddows (ref_12) 2021; 97
Mahal (ref_20) 2019; 28
Haeggblom (ref_27) 2019; 41
Drake (ref_9) 2021; 127
Mena (ref_14) 2020; 10
ref_10
Hansen (ref_21) 2018; 8
Cerezo (ref_16) 2014; 16
Alemany (ref_6) 2016; 108
Zamani (ref_18) 2020; 134
Rodrigo (ref_13) 2014; 134
Nascimento (ref_11) 2019; 93
Ang (ref_5) 2010; 363
Faraji (ref_25) 2019; 125
Frayle (ref_17) 2020; 10
Curado (ref_24) 2011; 35
Herrero (ref_1) 2003; 95
Woods (ref_3) 2014; 2
Mehanna (ref_15) 2020; 31
(ref_31) 2012; 9
ref_23
Timbang (ref_32) 2019; 15
Evans (ref_19) 2013; 13
Heck (ref_30) 2009; 39
Chaturvedi (ref_4) 2011; 29
Kreimer (ref_2) 2007; 356
ref_8
Curado (ref_22) 2012; 48
Wittekindt (ref_28) 2019; 12
References_xml – volume: 125
  start-page: 761
  year: 2019
  ident: ref_25
  article-title: The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status
  publication-title: Cancer
  doi: 10.1002/cncr.31841
  contributor:
    fullname: Faraji
– volume: 97
  start-page: 458
  year: 2021
  ident: ref_12
  article-title: Human papillomavirus (HPV) vaccination and oropharyngeal HPV in ethnically diverse, sexually active adolescents: Community-based cross-sectional study
  publication-title: Sex. Transm. Infect.
  doi: 10.1136/sextrans-2020-054428
  contributor:
    fullname: Beddows
– volume: 10
  start-page: 9320
  year: 2020
  ident: ref_17
  article-title: Age-independent increasing prevalence of Human Papillomavirus-driven oropharyngeal carcinomas in North-East Italy
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-66323-z
  contributor:
    fullname: Frayle
– volume: 9
  start-page: 121
  year: 2012
  ident: ref_31
  article-title: Sexual behaviors among older adults in Spain: Results from a population-based national sexual health survey
  publication-title: J. Sex. Med.
  doi: 10.1111/j.1743-6109.2011.02511.x
– volume: 31
  start-page: S599
  year: 2020
  ident: ref_15
  article-title: Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study
  publication-title: Ann. Oncol.
  doi: 10.1016/j.annonc.2020.08.1026
  contributor:
    fullname: Mehanna
– volume: 8
  start-page: e019005
  year: 2018
  ident: ref_21
  article-title: Long-term incidence trends of HPVrelated cancers, and cases preventable by HPV vaccination: A registry-based study in Norway
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2017-019005
  contributor:
    fullname: Hansen
– volume: 31
  start-page: 4550
  year: 2013
  ident: ref_7
  article-title: Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2013.50.3870
  contributor:
    fullname: Chaturvedi
– volume: 93
  start-page: e1
  year: 2019
  ident: ref_11
  article-title: Evolution of sexual health in spanish and asturian adolescents
  publication-title: Rev. Esp. Salud. Publica
  contributor:
    fullname: Nascimento
– volume: 134
  start-page: 487
  year: 2014
  ident: ref_13
  article-title: Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990–2009)
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.28355
  contributor:
    fullname: Rodrigo
– volume: 16
  start-page: 301
  year: 2014
  ident: ref_16
  article-title: Oropharyngeal cancer related to Human Papilloma Virus: Incidence and prognosis in Madrid, Spain
  publication-title: Clin. Transl. Oncol.
  doi: 10.1007/s12094-013-1074-5
  contributor:
    fullname: Cerezo
– volume: 41
  start-page: 1583
  year: 2019
  ident: ref_27
  article-title: Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue càncer during 2000-2016 in the Stockholm region and Sweden
  publication-title: Head Neck
  doi: 10.1002/hed.25585
  contributor:
    fullname: Haeggblom
– volume: 95
  start-page: 1772
  year: 2003
  ident: ref_1
  article-title: Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/djg107
  contributor:
    fullname: Herrero
– volume: 363
  start-page: 24
  year: 2010
  ident: ref_5
  article-title: Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa0912217
  contributor:
    fullname: Ang
– volume: 12
  start-page: 375
  year: 2019
  ident: ref_28
  article-title: Increasing incidence rates of oropharyngeal squamous cell carcinoma in Germany and significance of disease burden attributed to human papillomavirus
  publication-title: Cancer Prev. Res.
  doi: 10.1158/1940-6207.CAPR-19-0098
  contributor:
    fullname: Wittekindt
– volume: 10
  start-page: 13219
  year: 2020
  ident: ref_14
  article-title: Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-70118-7
  contributor:
    fullname: Mena
– volume: 2
  start-page: 172
  year: 2014
  ident: ref_3
  article-title: Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review
  publication-title: World J. Clin. Cases
  doi: 10.12998/wjcc.v2.i6.172
  contributor:
    fullname: Woods
– ident: ref_8
– volume: 356
  start-page: 1944
  year: 2007
  ident: ref_2
  article-title: Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa065497
  contributor:
    fullname: Kreimer
– volume: 48
  start-page: 484
  year: 2012
  ident: ref_22
  article-title: International incidence of oropharyngeal cancer: A population-based study
  publication-title: Oral Oncol.
  doi: 10.1016/j.oraloncology.2011.12.013
  contributor:
    fullname: Curado
– ident: ref_10
– ident: ref_23
  doi: 10.3390/v13071326
– volume: 311
  start-page: 183
  year: 2014
  ident: ref_29
  article-title: Smoking prevalence and cigarette consumption in 187 countries, 1980-2012
  publication-title: JAMA
  doi: 10.1001/jama.2013.284692
  contributor:
    fullname: Ng
– volume: 108
  start-page: djv403
  year: 2016
  ident: ref_6
  article-title: HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/djv403
  contributor:
    fullname: Alemany
– volume: 39
  start-page: 166
  year: 2009
  ident: ref_30
  article-title: Sexual behaviours and the risk of head and neck cancers: A pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/dyp350
  contributor:
    fullname: Heck
– volume: 13
  start-page: 220
  year: 2013
  ident: ref_19
  article-title: Human Papillomavirus-associated oropharyngeal cancer: An observational study of diagnosis, prevalence, and prognosis in a UK population
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-13-220
  contributor:
    fullname: Evans
– volume: 134
  start-page: 52
  year: 2020
  ident: ref_18
  article-title: The current epidemic of HPV-associated oropharyngeal cancer: An 18-year Danish population-based study with 2169 patients
  publication-title: Eur. J. Cancer
  doi: 10.1016/j.ejca.2020.04.027
  contributor:
    fullname: Zamani
– volume: 15
  start-page: 1920
  year: 2019
  ident: ref_32
  article-title: HPV-related oropharyngeal cancer: A review on burden of the disease and opportunities for prevention and early detection
  publication-title: Hum. Vaccin. Immunother.
  doi: 10.1080/21645515.2019.1600985
  contributor:
    fullname: Timbang
– volume: 29
  start-page: 4294
  year: 2011
  ident: ref_4
  article-title: Human papillomavirus and rising oropharyngeal cancer incidence in the United States
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2011.36.4596
  contributor:
    fullname: Chaturvedi
– volume: 127
  start-page: 1029
  year: 2021
  ident: ref_9
  article-title: Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer
  publication-title: Cancer
  doi: 10.1002/cncr.33346
  contributor:
    fullname: Drake
– volume: 35
  start-page: 510
  year: 2011
  ident: ref_24
  article-title: Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control
  publication-title: Cancer Epidemiol.
  doi: 10.1016/j.canep.2011.02.012
  contributor:
    fullname: Curado
– volume: 28
  start-page: 1660
  year: 2019
  ident: ref_20
  article-title: Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States
  publication-title: Cancer Epidemiol. Biomark. Prev.
  doi: 10.1158/1055-9965.EPI-19-0038
  contributor:
    fullname: Mahal
– volume: 143
  start-page: 283
  year: 2018
  ident: ref_26
  article-title: Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.31315
  contributor:
    fullname: Rietbergen
SSID ssj0038469
Score 2.360408
Snippet Human papilloma virus (HPV)-related oropharyngeal carcinoma (OPC) can be considered a new subtype of cancer with different clinical characteristics and...
Introduction: Human papilloma virus (HPV)-related oropharyngeal carcinoma (OPC) can be considered a new subtype of cancer with different clinical...
Introduction: Human papilloma virus (HPV)-related oropharyngeal carcinoma (OPC) can be considered a new subtype of cancer with different clinical...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 4802
SubjectTerms Adenomatous polyposis coli
Age
Alphapapillomavirus
Epidemiology
Europe - epidemiology
Head & neck cancer
Human papillomavirus
Humans
Incidence
Infections
Mouth
Neoplasms
Oropharyngeal cancer
Oropharyngeal Neoplasms - epidemiology
Papillomaviridae
Papillomavirus Infections - epidemiology
Population
Prognosis
Software
Survival
Throat cancer
Tobacco
Trends
Tumors
Viruses
Title Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe
URI https://www.ncbi.nlm.nih.gov/pubmed/35457669
https://www.proquest.com/docview/2652980984
https://search.proquest.com/docview/2654283677
https://pubmed.ncbi.nlm.nih.gov/PMC9027195
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB7RPSEhxJuwy8pISJy8bWInjo9QdrWIV8UC4hY5sc0GtU6VboT4MfxXxnZTbeHG2U9lxvNwPn8D8BydVK0xjKaZShnlteW0LJUNKAtZznBQqHV4fiE-fCtfn3qanHx8CxNA-03dnrjl6sS1lwFbuV410xEnNl28n0vMpVKZTycwwdhwTNGj-WXoUH3Mm6Ljoej-RGRqZJjbT9sfBjePLrDk5czXsWEYP4jCg52vO6V_Is2_AZPXPNDZHbi9DR3Jy7jFu3DDuHtwK967kfic6D78XuwqctFX6KE0GWlHSGdJRMCS1hG0C7GcKFFOk4sBLQbqnO8TrvXJQq3b5bJbKfK17YcNDaA5nO1j360vVf_LfccFydzrTO_nU-Rd95PGRxHkk_EoZz9ZqNBnekfirf8D-HJ2-nl-TrclGGjDGENbyYzOC2aNpzXjWaM0K0Vm8iZVja2FFoViFo0tJkZaN9JqqdOapzPj0yBZaPYQDlznzGMgkttc4Oe2NUYtCk2JqlmuubSyaGrBdQIvRhlU68i0UWGG4gVX7QsugaNRRNX2xG2qrMgzVC5Z8gSe7ZrxrPgfIMqZbgh9PL9cIUQCj6JEd0uNqpCA2JP1roPn4d5vQfUMfNxbdXzy3yMP4WbmX1V4Csn8CA6u-sE8hclGD8cY5b95exw0_A_dxQHz
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RcgAJ8X4EChgJiVO6SZzE8bHdtlrEtqxoQdwiJ7Zp0K6zyhIhfgz_tWN7s-rCrWc7tqUZzyP-5huA9-ikKolhdJiImIZppdOwKIR2KAteRPiR63U4OWdn34ujY0uTkw21MA60X1fNvpkv9k1z6bCVy0U9GnBio9npmGMuFfNstAO38b5G0ZCkewNM0aXaqDdG1xOiA2Seq5Fidj9qfio8PjrBIi0i28mGYgTBcgt3vu6W_os1_4VMXvNBJw9uePqHcH8ddJIDP_wIbinzGO75P3bEFyI9gb-zTS-v8BB9myQDYQlpNfHYWdIYghbFNyIlwkhy3qOtQW21c9yDAJmJZTOftwtBvjVdvwod3A5X-9y1y0vR_TE_cEMyttrW2fUEmba_Q19OQb4oi4-2i7nefqozxL8XPIWvJ8cX40m4bt4Q1pRStLJUySynWllCtDSphaQFS1RWx6LWFZMsF1SjmcaUSsqaa8llXKVxpGwCxXNJn8GuaY16AYSnOmMoJl1hvCPQCImKZjLlmud1xVIZwIdBduXSc3SUmNtYgZfbAg9gbxBtub6rqzLJswTVkhdpAO82w3jL7NOJMKrt3RzLTJczFsBzrwmbrQYVCoBt6chmgmXw3h5B1XBM3mtVeHnjL9_CncnF6bScfjz79AruJrY2wxJRZnuw-6vr1WvYWcn-jbsfVx-aFoM
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFD5iQ5omIe6DwAAjIfGUpYmTOH6EbtUQY1QMEG-RE9ssqHWilAjxY_ivHNtNtcIbPMcXWecef_4OwAsMUpXENDpMREzDtNJpWBRCO5QFLyY4yfU6PL1g51-K4xNLk7Np9eVA-3XVHJnF8sg0lw5b2S3raMSJRfN3U461VMyzqJM62oHraLOTZCzUvROmGFZt5htj-AkxCDLP10ixwo-abwqPgIGwSHHePuxRzCJYbiHPV0PTX_nmn7DJK3Fodus_TnAbbq6TT_LKD7kD15S5Czf8nzviHyTdg1_zTU-v8DXGOElG4hLSauIxtKQxBD2Lb0hKhJHkYkCfg1prx7iLATIXXbNYtEtBPjf9sAod7A5Xe9-33aXof5qvuCGZWq3r7XqCnLU_Qv-sgnxQFidtF3M9_lRviL83uA-fZicfp6fhuolDWFNK0dtSJbOcamWJ0dKkFpIWLFFZHYtaV0yyXFCN7hpLKylrriWXcZXGE2ULKZ5LegC7pjXqIRCe6oyhqHSFeY9AZyQqmsmUa57XFUtlAC9H-ZWd5-ooscaxQi-3hR7A4Sjecm2zqzLJswTVkxdpAM83n9Ha7BWKMKod3BjLUJczFsADrw2brUY1CoBt6clmgGXy3v6C6uEYvdfq8OifZz6DvfnxrDx7c_72Mewn9omG5aPMDmH3ez-oJ7CzksNTZyK_AcxlGQM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Population-Based+Analysis+of+Trends+in+Incidence+and+Survival+of+Human+Papilloma+Virus-Related+Oropharyngeal+Cancer+in+a+Low-Burden+Region+of+Southern+Europe&rft.jtitle=International+journal+of+environmental+research+and+public+health&rft.au=Rubi%C3%B3-Casadevall%2C+Jordi&rft.au=Ciurana%2C+Elna&rft.au=Puigdemont%2C+Montserrat&rft.au=Sanvisens%2C+Arantza&rft.date=2022-04-15&rft.pub=MDPI+AG&rft.issn=1661-7827&rft.eissn=1660-4601&rft.volume=19&rft.issue=8&rft.spage=4802&rft_id=info:doi/10.3390%2Fijerph19084802&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1660-4601&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1660-4601&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1660-4601&client=summon